...
首页> 外文期刊>Human mutation >Targeted exome sequencing in clear cell renal cell carcinoma tumors suggests aberrant chromatin regulation as a crucial step in ccRCC development
【24h】

Targeted exome sequencing in clear cell renal cell carcinoma tumors suggests aberrant chromatin regulation as a crucial step in ccRCC development

机译:针对透明细胞肾细胞癌肿瘤的靶向外显子组测序表明,异常的染色质调节是ccRCC发展的关键步骤

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Clear cell renal cell carcinomas are characterized by 3p loss, and by inactivation of Von Hippel Lindau (VHL), a tumorsuppressor gene located at 3p25. Recently, SETD2, located at 3p21, was identified as a new candidate ccRCC tumor-suppressor gene. The combined mutational frequency in ccRCC tumors of VHL and SETD2 suggests that there are still undiscovered tumor-suppressor genes on 3p. We screened all genes on 3p for mutations in 10 primary ccRCC tumors using exome-sequencing. We identified inactivating mutations in VHL, PBRM1, and BAP1. Sequencing of PBRM1 in ccRCC-derived cell lines confirmed its frequent inactivation in ccRCC. PBRM1 encodes for BAF180, the chromatin targeting subunit of the SWI/SNF complex. BAP1 encodes for BRCA1 associated protein-1, involved in histone deubiquitination. Taken together, the accumulating data suggest an important role for aberrant chromatin regulation in ccRCC development.
机译:透明细胞肾细胞癌的特征是3p丢失,以及灭活Von Hippel Lindau(VHL)(一种位于3p25的肿瘤抑制基因)。最近,位于3p21的SETD2被鉴定为新的候选ccRCC肿瘤抑制基因。 VHL和SETD2的ccRCC肿瘤的组合突变频率表明,在3p上仍存在未发现的肿瘤抑制基因。我们使用外显子组测序在3p上筛选了10个原发性ccRCC肿瘤中所有基因的突变。我们确定了VHL,PBRM1和BAP1中的失活突变。在源自ccRCC的细胞系中PBRM1的测序证实其在ccRCC中频繁失活。 PBRM1编码BAF180,SWI / SNF复合物的染色质靶向亚基。 BAP1编码BRCA1相关蛋白1,参与组蛋白去泛素化。综上所述,积累的数据表明异常的染色质调节在ccRCC发育中具有重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号